This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Duksung Women's University Industry-Academic Cooperation Foundation, Ewha University-Industry Collaboration Foundation, Industry Academic Cooperation Foundation of Yeungnam University. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2026
Title: Hyun Sung Cho: Innovator in Neurodegenerative Disease Treatment
Introduction
Hyun Sung Cho is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of neurodegenerative disease treatment through his innovative research and patents.
Latest Patents
Hyun Sung Cho holds a patent for a compound titled "1-alkyl-5-arylidene-2-selenoxoimidazolidine-4-on and derivative thereof, preparation method therefor, and composition comprising same for preventing, alleviating or treating neurodegenerative diseases." This invention relates to novel compounds that can be utilized as effective compositions for the prevention, improvement, or treatment of neurodegenerative diseases. The patent highlights the potential of these compounds in addressing critical health challenges.
Career Highlights
Throughout his career, Hyun Sung Cho has been associated with prominent institutions, including the KNU Industry Cooperation Foundation and the Ewha University-Industry Collaboration Foundation. His work in these organizations has allowed him to advance his research and collaborate with other experts in the field.
Collaborations
Hyun Sung Cho has worked alongside talented individuals such as Yoo Jin Lim and Dong Young Choi. Their collaborative efforts have contributed to the development of innovative solutions in the realm of neurodegenerative diseases.
Conclusion
Hyun Sung Cho's contributions to the field of neurodegenerative disease treatment through his patent and collaborations highlight his role as a significant inventor. His work continues to pave the way for advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile